Virpax Pharmaceuticals
高管
查看带有其 10 名主要高管的组织结构图
Virpax Pharmaceuticals 搜索最多的简介
高管在Virpax Pharmaceuticals变化
- Anthony Mack, Chief Executive Officer and Chairman of the Board, 已经离开公司 (新闻发布的2023十一月19号).
- Eric Floyd 曾任 Director, 现升职为 Chairman of the Board (新闻发布的2023十一月19号).
- Gerald Bruce 曾任 Executive Vice President, Commercial Operations, 现升职为 Chief Executive Officer (新闻发布的2023十一月19号).
创建提醒
跟踪 Virpax Pharmaceuticals 的高管变动
药店
Virpax Pharmaceuticals 拥有 1,862 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- MedMen has filed for bankruptcy protection (公布2024四月28号).
- AstraZeneca has announced the acquisition of Fusion Pharma (公布2024三月23号).
- AstraZeneca has announced the acquisition of Amolyt Pharma (公布2024三月19号).
药店 行业的其他推荐联系人
消息
Virpax Pharmaceuticals 的最新新闻稿
- Virpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council - MyChesCo
- Virpax plans three trials based on platform drug delivery systems in 2024
- Maxim Group Sticks to Their Buy Rating for Virpax Pharmaceuticals (VRPX) - TipRanks.com
- Maxim Group Reaffirms Their Buy Rating on Virpax Pharmaceuticals (VRPX)
- Virpax Completes FDA Required Preclinical Toxicology Studies For Its Licensed Molecular Envelope Technology - Virpax Pharmaceuticals (NASDAQ:VRPX)
- Press Releases | Virpax Pharmaceuticals
- Altasciences Chosen by Virpax Pharmaceuticals, Inc. to Conduct First-in-Human Study of Epoladerm™ for Chronic Pain Associated with Osteoarthritis of the Knee | Altasciences
- Virpax Pharmaceuticals Selects Kindeva Drug Delivery as Development Partner for Diclofenac pMDI Commercialization | Kindeva Complex Drug CDMO
- News
- New CBD nasal spray to target seizures in epilepsy
- View more press releases Close
通过电子邮件
